RESUMEN
UNLABELLED: The present study was conducted to evaluate the burden of pneumococcal meningitis in Austrian children between 2001 and 2008. Clinical outcome was retrospectively analyzed both on discharge and on follow-up investigations. This study was based on a prospective multicentre surveillance study on hospitalized invasive pneumococcal infections in Austrian children with a total annual "study population" of about 399,000 children aged below 5 years per year. Between 2001 and 2008, 74 cases of pneumococcal meningitis were identified in children aged below 5 years. The mean annual incidence rate for pneumococcal meningitis was 2.3 per 100,000 children in this age group. In 57/74 children (mean age on admission 14.5 ± 13.3 months), outcome data on hospital discharge were available: 5 deaths (8.8%), 20 children (35.1%) with sequelae and 32 children (56.1%) without sequelae were observed. Sequelae on discharge included motor impairment in 8 children (14.0%), hearing impairment in 9 children (15.8%) and/or other complications in 14 children (24.6%). In 7/8 children with motor deficits, matching cerebral lesions were identified by neuroimaging: cerebral infarction in five children, cerebral vasculitis and cerebral abscess in one child each. In 40/57 children, long-term outcome (18.9 ± 20.2 months after discharge) could be assessed: 1 child (2.5%) died 9 months after hospital discharge, 11 children (27.5%) had one or two long-term sequelae and 28 children (70.0%) had no sequelae. Long-term sequelae included motor impairment in three children (7.5%), hearing impairment in nine children (22.5%) and other deficits in two children (5.0%). CONCLUSION: Our study confirms that pneumococcal meningitis causes high mortality and severe long-term sequelae. On long-term follow-up, we observed improvements of motor impairment, but not of hearing impairment.
Asunto(s)
Meningitis Neumocócica/epidemiología , Streptococcus pneumoniae/aislamiento & purificación , Adolescente , Austria/epidemiología , Niño , Preescolar , Femenino , Estudios de Seguimiento , Hospitalización , Humanos , Incidencia , Lactante , Masculino , Meningitis Neumocócica/microbiología , Meningitis Neumocócica/mortalidad , Pronóstico , Estudios Prospectivos , Estudios RetrospectivosRESUMEN
OBJECTIVES: Diagnosis of Lyme neuroborreliosis (NB) depends on the proof of intrathecal antibody production against Borrelia burgdorferi. CXCL13 has been seen to be elevated early in NB, before antibody production has started. In this study, we determined the diagnostic role of the CXCL13 chemokine in cerebrospinal fluid (CSF) and serum for the first time in pediatric NB patients as well as in adults, compared to controls and blood donors (BD). MATERIAL AND METHODS: CXCL13 levels were measured in CSF and serum of 33 children and 42 adult patients. Serum CXCL13 was measured in 300 BD. RESULTS: CSF CXCL13 levels were significantly elevated in definite and probable acute NB in children and adults compared to seropositive and seronegative neurological controls (P < 0.001). Serum CXCL13 levels showed great fluctuations and were not significantly elevated in NB patients. CONCLUSIONS: Our study suggests that CSF CXCL13 can be used as a diagnostic marker for NB in children as well. In contrast, CXCL13 serum levels show great variance even in the healthy population and are not indicative of active NB.
Asunto(s)
Quimiocina CXCL13/sangre , Quimiocina CXCL13/líquido cefalorraquídeo , Neuroborreliosis de Lyme/diagnóstico , Adolescente , Adulto , Factores de Edad , Niño , Preescolar , Femenino , Humanos , Lactante , Recién Nacido , Neuroborreliosis de Lyme/sangre , Neuroborreliosis de Lyme/líquido cefalorraquídeo , Masculino , Persona de Mediana Edad , Regulación hacia Arriba/fisiología , Adulto JovenRESUMEN
BACKGROUND: The limited availability of microbiology services in sub-Saharan Africa impedes accurate diagnosis of bacterial pathogens and understanding of trends in prevalence and antibiotic sensitivities. We aimed to characterize bacteremia among hospitalized children in The Gambia and to identify factors associated with bacteremia and mortality. METHODS: We prospectively studied children presenting with suspected severe infection to 2 urban hospitals in The Gambia, between January 2013 and September 2015. Demographic and anthropometric data, clinical features, management, and blood culture results were documented. Urine screens for antibiotic activity were performed in a subset of participants. RESULTS: Of 411 children enrolled (median age, 29 months; interquartile range, 11-82), 79.5% (325 of 409) reported prehospital antibiotic use. Antimicrobial activity by urinary screen for antibiotic activity was detected in 70.8% (n = 80 of 113). Sixty-six bacterial pathogens were identified in 65 (15.8%) participants and Staphylococcus aureus predominated. Gram-positive organisms were more commonly identified than Gram-negative (P < .01). Antibiotic resistance against first-line antimicrobials (ampicillin and gentamicin) was common among Gram-negative bacteria (39%; range, 25%-100%). Factors significantly associated with bacteremia included the following: gender, hydration status, musculoskeletal examination findings, admission to the Medical Research Council The Gambia at London School of Hygiene & Tropical Medicine hospital, and meeting sepsis criteria. Those associated with increased mortality were presence of a comorbidity, clinical pallor, tachypnea, and altered consciousness. Tachycardia was associated with reduced mortality. CONCLUSIONS: The bacteremia rate in children with suspected childhood life-threatening infectious diseases in The Gambia is high. The pattern of pathogen prevalence and antimicrobial resistance has changed over time compared with previous studies illustrating the importance of robust bacterial surveillance programs in resource-limited settings.
RESUMEN
BACKGROUND: Meningococcal disease may present as sepsis, meningitis or a combination of both. Impaired fibrinolysis and massive elevation of the plasminogen activator inhibitor-1 (PAI-1) is a characteristic feature of meningococcal sepsis. We and others have reported an association between mortality and the functional 4G/5G promoter polymorphism of the PAI-1 gene in children with meningococcal sepsis. OBJECTIVE: Multicenter study to investigate the association of the 4G/5G PAI-1 polymorphism and disseminated intravascular coagulation (DIC) in children with meningococcal disease in a Central European population. PATIENTS/METHODS: Blood samples and clinical information of 326 previously healthy children with meningococcal infection were collected from 95 pediatric hospitals in Germany, Switzerland, Italy, and Austria from 2000 to 2002. RESULTS: DIC, defined as platelet counts below 100 G L(-1), increased D-dimer levels and prolonged prothrombin time, was significantly associated with the 4G4G genotype [31 of 63 (49%) vs. 55 of 175 (31%), P = 0.014], resulting in a hazard ratio (HR) of 1.5 (95% confidence interval 1.1-2.1) to develop DIC. Carriers of the 4G4G genotype showed significantly lower platelet counts (183 G L(-1) vs. 227 G L(-1), P = 0.009) on admission. Fibrinogen and C-reactive protein levels were not associated with the PAI-1 4G/5G polymorphism, nor were white blood cell counts. CONCLUSIONS: Our data show a correlation between the 4G4G genotype of the PAI-1 gene and development of DIC in meningococcal infection.
Asunto(s)
Coagulación Intravascular Diseminada/sangre , Coagulación Intravascular Diseminada/genética , Genotipo , Infecciones Meningocócicas/genética , Inhibidor 1 de Activador Plasminogénico/genética , Polimorfismo Genético , Regiones Promotoras Genéticas , Adolescente , Proteína C-Reactiva/metabolismo , Niño , Preescolar , Coagulación Intravascular Diseminada/complicaciones , Femenino , Fibrinógeno/genética , Fibrinógeno/metabolismo , Humanos , Lactante , Recién Nacido , Masculino , Infecciones Meningocócicas/complicacionesRESUMEN
OBJECTIVE: To investigate if the factor V Leiden mutation (F-V-LM) and/or the prothrombin gene G 20210 A variant (P-G20210A-V) are risk factors for acute stroke in Austrian children. PATIENTS: 33 children with acute ischemic stroke documented by computer tomography and/or magnetic resonance imaging of the brain were enrolled in an open multicenter survey. RESULTS: 6/33 children had F-V-LM (5 heterozygous, 1 homozygous). This represents 18% (95% CI: 6.7-39.9%) of our pediatric stroke population and thus exceeds the expected prevalence in the Austrian population of 4,6% (Fischer's exact test, p = 0.01). F-V-LM was not found in 11 children with neonatal stroke but in 6/22 children with stroke after the neonatal period. 5/6 children with F-V-LM had an underlying disorder that is a risk factor for stroke in children. The P-G20210A-V was detected in 1/26 (3.85%; 95% CI: 0.1-21.4%) patients. Comparison of the prevalence of P-G20210A-V in our study with that in the general population of Austria of 1% revealed no statistical significance (Fischer's exact test, p = 0.38). CONCLUSION: Our data suggest that the F-V-LM is a risk factor for acute stroke in Austrian children beyond the neonatal period. The P-G20210A-V apparently does not represent a risk factor for stroke in Austrian children.
Asunto(s)
Isquemia Encefálica/genética , Factor V/genética , Protrombina/genética , Secuencias Reguladoras de Ácidos Nucleicos/genética , Trombofilia/genética , Resistencia a la Proteína C Activada/epidemiología , Resistencia a la Proteína C Activada/genética , Austria/epidemiología , Isquemia Encefálica/epidemiología , Niño , Preescolar , Femenino , Frecuencia de los Genes , Predisposición Genética a la Enfermedad , Genotipo , Humanos , Lactante , Recién Nacido , Masculino , Factores de Riesgo , Trombofilia/epidemiologíaRESUMEN
Antibodies to hepatitis C (anti-HCV) were determined in 24 children and adolescents with congenital disorders of haemostasis. 13 out of 24 patients (54%) were positive for anti-HCV. Comparison of the prevalence of positive anti-HCV and the quantity of non-virus inactivated factor VIII concentrates administered before 1985 showed positive anti-HCV in 100% of patients receiving more than 300 U factor VIII/kg b.w./month, in 88% of patients receiving 100 to 300 U factor VIII/kg b.w./month, and in 60% of patients receiving less than 100 U/kg b.w./month. 13 out of all 16 patients (81%) treated with non-virus-inactivated concentrates before 1985 were positive for anti-HCV. In contrast, all patients treated with virus inactivated concentrates were negative for anti-HCV. Elevated aminotransferases were frequently found in 8 out of 13 patients (62%) positive for anti-HCV, but only in 3 out of 11 patients (27%) negative for anti-HCV. The risk of developing chronic hepatitis was about 2.5-fold higher in patients positive for hepatitis C-antibodies than in patients negative for hepatitis C-antibodies.
Asunto(s)
Hemofilia A/inmunología , Hepacivirus/inmunología , Anticuerpos Antihepatitis/análisis , Hepatitis C/inmunología , Adolescente , Niño , Factor VIII/uso terapéutico , Hemofilia A/terapia , Hepatitis B/diagnóstico , Hepatitis B/inmunología , Hepatitis B/transmisión , Anticuerpos contra la Hepatitis B/análisis , Hepatitis C/diagnóstico , Hepatitis C/transmisión , Humanos , Pruebas de Función Hepática , Factores de RiesgoRESUMEN
Increasing tourism and growing numbers of immigrants from malaria-endemic countries are leading to a higher importation rate of rare tropical disorders in European countries. We describe, to the best of our knowledge, the first case of connatal malaria in Austria. The patient is the first child of a 24 year old mother who was born in Ghana and immigrated to Austria one and a half years before delivery. She did not stay in an endemic region during this period and did not show fever or any other signs of malaria. The boy was healthy for the first six weeks of his life. In the 8th week of life he was admitted to our hospital due to persistent fever of unknown origin. On physical examination he showed only mild splenomegaly. Routine laboratory testing revealed mild hemolytic anemia with a hemoglobin value of 8.3 g/l. In the blood smear Plasmodium falciparum and Plasmodium malariae were detected. Oral therapy with quinine hydrochloride was successful and blood smears became negative for Plasmodia within 6 days. This case shows that congenital malaria can occur in children of clinically healthy women who were born in malaria-endemic areas even one and a half year after they have immigrated to non-endemic regions.
Asunto(s)
Malaria/congénito , Malaria/parasitología , Plasmodium falciparum/aislamiento & purificación , Plasmodium malariae/aislamiento & purificación , Adulto , Animales , Antimaláricos/uso terapéutico , Austria/epidemiología , Femenino , Fiebre de Origen Desconocido/parasitología , Ghana/etnología , Humanos , Lactante , Transmisión Vertical de Enfermedad Infecciosa , Malaria/diagnóstico , Malaria/terapia , Malaria Falciparum/congénito , Malaria Falciparum/diagnóstico , Masculino , Quinina/uso terapéutico , Factores de Tiempo , Resultado del TratamientoRESUMEN
OBJECTIVE: To evaluate the association between maternal interleukin (IL)-6 G(-174)C polymorphism and cystic periventricular leukomalacia (cPVL) of the preterm newborn. STUDY DESIGN: After searching a local database, we recruited 132 preterm infants with diagnosis of cPVL, 44 Caucasian mothers were also recruited to participate in this candidate gene-association study at a single teritary care center. Data related to maternal IL-6 G(-174)C polymorphisms were compared with 41 controls, and furthermore compared with data from umbilical cord blood samples from a consecutive birth cohort of 395 healthy newborns, and published data from Caucasian populations including 1104 adults, respectively. In addition, subgroup analysis was performed in cases with either history of preterm premature rupture of the membranes (PPROM) or clinical chorioamnionitis (CCA). IL-6 genotyping was performed using an allele-specific polymerase chain reaction technique. RESULT: Frequencies of the IL-6 G(-174)C polymorphisms did not differ between cases (GG, 29.5%; GC, 54.5% and CC, 15.9%) and controls (GG, 34.2; GC, 51.2 and CC, 14.6%). Subgroup analysis of 31 cases with history of PPROM (GG, 25.8; GC, 54.8 and CC 19.4%) and controls did not reveal significant differences, but a significantly higher frequency of the CC genotype was found in 23 cases with a history of CCA (34.8%) compared with controls by either univariate (P=0.032; odds ratio 3.11, 95% confidence interval (CI) 1.11 to 8.68) or multivariate analysis (P=0.049, odds ratio 2.54, 95% CI 1.01 to 6.45). These data were confirmed by a comparing the CC genotype frequency to 395 term controls (CC 14.7%, P=0.005) and to the mean CC genotype frequency of 1104 Caucasian adults (CC 15.6%, P<0.0001). CONCLUSION: Frequencies of the IL-6 G(-174)C polymorphisms did not differ between groups. Subgroup analysis revealed an association of the CC genotype with CCA and cPVL in the preterm newborn.
Asunto(s)
Corioamnionitis/genética , Recien Nacido Prematuro , Interleucina-6/genética , Leucomalacia Periventricular/genética , Polimorfismo Genético , Adulto , Austria , Corioamnionitis/sangre , Femenino , Estudios de Asociación Genética , Predisposición Genética a la Enfermedad/embriología , Humanos , Recién Nacido , Recien Nacido Prematuro/sangre , Interleucina-6/sangre , Embarazo , Adulto JovenAsunto(s)
Bacteriemia/tratamiento farmacológico , Infecciones Meningocócicas/tratamiento farmacológico , Choque Séptico/tratamiento farmacológico , Activador de Tejido Plasminógeno/uso terapéutico , Femenino , Humanos , Vasculitis por IgA/tratamiento farmacológico , Vasculitis por IgA/etiología , Lactante , Masculino , Infecciones Meningocócicas/complicaciones , Proteínas Recombinantes/uso terapéutico , Choque Séptico/etiologíaAsunto(s)
Deficiencia de Proteína S , Púrpura/etiología , Piel/patología , Niño , Coagulación Intravascular Diseminada/etiología , Femenino , Humanos , Infecciones Meningocócicas/complicaciones , Necrosis , Faringitis/complicaciones , Proteína C/análisis , Deficiencia de Proteína C , Choque Séptico/complicaciones , Infecciones Estreptocócicas/complicacionesAsunto(s)
Fibrinolíticos/uso terapéutico , Trombosis/tratamiento farmacológico , Niño , Preescolar , HumanosAsunto(s)
Procedimientos Quirúrgicos Cardíacos , Factor V/antagonistas & inhibidores , Adhesivo de Tejido de Fibrina/efectos adversos , Hemorragia/etiología , Complicaciones Posoperatorias , Trombina/efectos adversos , Animales , Bovinos , Preescolar , Factor V/inmunología , Humanos , Masculino , Trombina/inmunologíaAsunto(s)
Bacteriemia/sangre , Coagulación Intravascular Diseminada/tratamiento farmacológico , Infecciones Meningocócicas/sangre , Inhibidor 1 de Activador Plasminogénico/fisiología , Choque Séptico/sangre , Activador de Tejido Plasminógeno/uso terapéutico , Animales , Bacteriemia/complicaciones , Bacteriemia/tratamiento farmacológico , Coagulación Intravascular Diseminada/etiología , Femenino , Fibrinólisis , Humanos , Lactante , Masculino , Infecciones Meningocócicas/complicaciones , Infecciones Meningocócicas/tratamiento farmacológico , Proteína C/uso terapéutico , Deficiencia de Proteína C , Conejos , Proteínas Recombinantes/uso terapéutico , Choque Séptico/complicaciones , Choque Séptico/tratamiento farmacológico , Estreptoquinasa/uso terapéuticoAsunto(s)
Histiocitosis de Células no Langerhans , Enfermedades Pulmonares Intersticiales , Diarrea Infantil/etiología , Resultado Fatal , Histiocitosis de Células no Langerhans/complicaciones , Histiocitosis de Células no Langerhans/diagnóstico , Histiocitosis de Células no Langerhans/genética , Humanos , Lactante , Enfermedades Pulmonares Intersticiales/diagnóstico , Enfermedades Pulmonares Intersticiales/etiología , Masculino , Índice de Severidad de la EnfermedadAsunto(s)
Pruebas de Coagulación Sanguínea , Adhesivo de Tejido de Fibrina/administración & dosificación , Cardiopatías Congénitas/cirugía , Ventrículos Cardíacos/anomalías , Arteria Pulmonar/anomalías , Trombina/antagonistas & inhibidores , Niño , Femenino , Adhesivo de Tejido de Fibrina/efectos adversos , Fibrinógeno/metabolismo , Estudios de Seguimiento , Cardiopatías Congénitas/sangre , Ventrículos Cardíacos/cirugía , Humanos , Arteria Pulmonar/cirugía , Trombina/metabolismoRESUMEN
The increasing heterosexual transmission of HIV leads to an increase of vertical HIV-infection from mother to child. In Austria 19 children below 13 years with AIDS are registered, 16 of them had been infected by their mothers (österreichische AIDS-Statistik, January 29, 1993). Clinical manifestations of HIV-infection in infants and children are different from those in adults. In this article we describe the typical signs like severe recurrent bacterial infections, failure to thrive, lymphoid interstitial pneumonia and neurologic symptoms as developmental delay, loss of previous acquired skills and progressive motor abnormalities. The difficulties of the diagnosis of HIV-infection in an infant born to a seropositive mother and problems with the integration of HIV-infected children in kindergarten and school are discussed.
Asunto(s)
Complejo SIDA Demencia/diagnóstico , Infecciones Oportunistas Relacionadas con el SIDA/diagnóstico , Infecciones por VIH/diagnóstico , Complejo SIDA Demencia/epidemiología , Complejo SIDA Demencia/transmisión , Infecciones Oportunistas Relacionadas con el SIDA/epidemiología , Infecciones Oportunistas Relacionadas con el SIDA/transmisión , Adolescente , Austria/epidemiología , Niño , Preescolar , Femenino , Infecciones por VIH/epidemiología , Infecciones por VIH/transmisión , Humanos , Lactante , Recién Nacido , MasculinoRESUMEN
Gitoformat, a new derivate of Gitoxin, was tested with 50, mainly geriatic patients with a manifested cardiac insufficiency. The initial treatment as well as a changeover from the usual glycosid-treatment after a renewed decompensation was without any problems. With a rate of success of 95 per cent the efficiency of this new glycosid can be classified as excellent. Side effects or incompatibility were consequences of overdosage. It is remarkable that also patients with a reduced renal function did not need a reduction in dose. At 10 patients the recompensation with Gitoformat continued after discharge over an observation period of 6 months. The maintenance dose had not to be changed, incompatibility or overdosage reactions didn't appear.
Asunto(s)
Glicósidos Cardíacos/uso terapéutico , Insuficiencia Cardíaca/tratamiento farmacológico , Anciano , Glicósidos Cardíacos/efectos adversos , Evaluación de Medicamentos , Femenino , Humanos , Masculino , Persona de Mediana EdadRESUMEN
In 1977 Brackmann for the first time reported an induction of tolerance in hemophiliacs with inhibitors using a protocol requiring administration of very high daily doses of factor VIII and activated prothrombin complex concentrates. Since the costs of such a protocol are enormous, we report our experiences in 3 hemophiliac children with inhibitors against factor VIII treated with much lower doses of factor VIII concentrate only for induction of tolerance. Two "high responder" and one "low responder" initially for only a short period received factor VIII concentrate in doses comparable to the Brackmann protocol. After that period patients were treated with 25--30 units factor VIII concentrate/kg/day, doses that are comparable to conventional prophylactic treatment. In one high responder the inhibitor disappeared completely after 22 months, in the other high responder the inhibitor titer decreased from 133 BU to 4.4 BU. In the low responder also a significant decrease of the inhibitor titer was observed. At this time bleedings in all three patients can be controlled by conventional doses of factor VIII concentrate.